Tumour compression on the airways or the great vessels may create a critical respiratory and/or haemodynamic situation, and therefore the standard of intraoperative management includes induction of anaesthesia in the operating theatre on an adjustable surgical table, the use of short-acting anaesthetics, avoidance of muscle relaxants and maintenance of spontaneous respiration. In the case of severe clinical symptoms and large mediastinal tumours, we consider it absolutely essential to cannulate the femoral vessels preoperatively under local anaesthesia and to provide for the availability of cardiopulmonary bypass in the operating theatre, should extracorporeal circulation become necessary. The benefits of establishing vascular access under local anaesthesia clearly outweigh any associated degree of patient discomfort. In the case of patients classified as 'safe' or 'uncertain', a preoperative consensus with the surgeons should be reached as to the anaesthetic approach and the management of possible complications. Eur J Anaesthesiol 26:627-632 Q 2009 European Society of Anaesthesiology.
Introduction
The anaesthetic management of patients with mediastinal mass represents a particular clinical challenge for the anaesthesiologist. Mediastinal tumours do not form a homogenous group. They differ considerably with regard to nature, clinical evolution, size and topographic distribution. This produces a great variety of ways in which the vital organs in the restricted mediastinal space may be impaired. Thus, the clinical symptoms are always unique, as are the diagnostic and treatment options. Depending on the tumour-caused changes in the mediastinum, the respiratory and haemodynamic responses to anaesthesia in patients with mediastinal mass vary tremendously.
Insufficient preoperative diagnosis, incorrect preoperative preparation or inadequate anaesthetic technique can quickly result in life-threatening situations or a fatal outcome. Although there are many case reports that describe decompensation following induction of anaesthesia in patients with a mediastinal tumour [1] [2] [3] [4] , no standard protocols providing the details of the perioperative procedure for this anaesthetically relevant disease have been developed.
Based on a review of the latest literature and own clinical experiences, the aim of this article is to summarize the genesis of and the diagnostic options for mediastinal mass syndrome (MMS) and to provide a solid detailed methodology for its safe perioperative management.
Definition and causes of mediastinal mass syndrome
MMS refers to the clinical picture caused by a mediastinal mass in anaesthetized patients. At every stage of anaesthesia, as well as postoperatively, this syndrome can very quickly result in acute respiratory or haemodynamic decompensation or both.
The respiratory decompensation is caused by mechanical compression of the trachea or main bronchi or both by the tumour. The compromising of the airways when the patient is conscious and the body is in an upright position leads to more or less distinctive clinical symptoms. A change in physiological pressure conditions in the respiratory tract due to positioning of the patient during surgery, or as a result of induction of general anaesthesia with positive pressure ventilation, can cause a critical increase in airway pressure with more difficult or even impossible ventilation and consecutive hypoxia. There are a number of reasons for the critical increase in airway pressure due to patient positioning: placing the patient supine (e.g. during anaesthesia induction) causes a reduction in the transverse diameter of the thorax and a cephalad displacement of the diaphragm. In addition, the central blood volume increases, leading to a considerable increase in the size of well vascularized mediastinal tumours. Overall, the postural changes cause further reduction in the thoracic airway cross-sectional area and, at the same time, an increase in external compression pressure on the airways. Induction of general anaesthesia further aggravates the critical respiratory situation. Under anaesthesia, the transverse diameter of the thorax is reduced, the inspiratory muscle tone decreases and, at the same time, the reduction in abdominal muscle tone results in cephalad displacement of abdominal contents. This causes a reduction in thoracic volume of around 500-1000 ml [3, 5] . Simultaneous relaxation of the bronchial smooth muscles increases the extent to which the large airways can be compressed. If neuromuscular blockade is used, absent craniocaudal movement of the diaphragm reduces the transpleural gradient. With the loss of spontaneous breathing during controlled ventilation, there is preferential ventilation of poorly perfused anterior lung sections, dorsal atelectasis formation, ventilation/perfusion mismatch and increase in shunt. A reduction in the cross-section of the airways and acceleration of gas molecules leads to the occurrence of turbulent poststenotic flow, which, in contrast to the laminar flow during spontaneous breathing, may be insufficient for ventilation of the distal bronchi. The result is reduced gas exchange, shunt and air trapping. Ultimately, the increased intrathoracic pressure with mechanical ventilation can cause the tumour to press against adjacent mediastinal organs, further aggravating the negative changes at the restricted airways [6] .
Respiratory decompensation may not manifest itself until the postoperative phase, even if the intraoperative phase remains complication-free [7] . Surgical complications (e.g. haemothorax, pneumothorax, diaphragmatic elevation due to lesion of the phrenic nerve) as well as the formation of oedema at the site of the operation can cause tracheal obstruction following extubation. Restricted ventrodorsal movement of the thoracic wall in patients who are not yet fully conscious or who are in pain following the intervention can lead to airway obstruction in the recovery room. Further, mediastinal masses attached to the thoracic wall can cause a critical stenosis at the trachea and primary bronchi [5] .
Haemodynamic decompensation may occur if the heart or major vessels (pulmonary artery, superior vena cava) are surrounded or infiltrated by the mediastinal tumour. Both pulmonary arteries are only a short distance from the aorta and the tracheobronchial system, which largely protects them from mechanical compression [8] . Nevertheless, if pulmonary artery diameter is reduced, impairment of pulmonary perfusion, hypoxemia, acute right ventricle failure and, potentially, cardiac arrest can occur. Whereas in daily life such patients are usually asymptomatic, they decompensate quickly if the pulmonary arterial circulation drops below the critical level. Induction of general anaesthesia, positioning supine on the operating table, the administration of muscle relaxants and the induction of positive pressure ventilation can represent possible triggers. In contrast to the pulmonary artery, the superior vena cava is particularly susceptible to external compression, due to its low intravascular pressure, thin vascular wall and the adjacent firm structures (pericaval lymph nodes, primary bronchus). With reduced venous drainage of the upper half of the body, right ventricular filling decreases and cardiac output drops. Even preoperatively, superior vena cava compression syndrome (SVCS) can represent a lifethreatening situation that requires rapid diagnosis and treatment [8, 9] . Just like constriction of the pulmonary artery, direct compression of the heart is also a similarly rare occurrence. However, large tumours (e.g. lymphoma and thymoma) can directly involve the heart and cause arrhythmias or low-output syndrome due to pericardial tamponade (e.g. a tumourrelated effusion) [7] .
Owing to the proximity of the mediastinal organs, in the majority of cases, a combination of haemodynamic and respiratory decompensation syndrome is encountered.
Diagnosis of mediastinal mass syndrome
Clinical examination provides the first diagnostic signs of MMS. Dyspnoea, cough, hoarseness or syncope, especially when moving the patient from a vertical to a horizontal position, are signs that must be taken seriously. The presence of oedema in the patient's upper body (face, neck, lids or larynx) and dilatation and/or failure of jugular, arm and thoracic veins to collapse are pathognomonic signs of involvement of the superior vena cava in a mediastinal process.
Even if patient history and clinical examination are reassuring, the administration of anaesthesia cannot always be regarded as safe. Patients who showed no preoperative symptoms can also develop very severe complications perioperatively [3, 5] . Verification of possible cardiorespiratory compromise must, therefore, be supplemented by the use of additional tests.
Apart from chest radiographs, spiral computed tomography (CT) has become the established standard. Modern scanners take less than 20 s and also allow the upper body to be elevated to 308 without affecting scan quality. CT not only provides exact details on the size and location of the tumour, but also permits accurate measurements of the airway diameters. A cross-sectional tracheal area less than 50% of normal diameter on CT can predict frequent perioperative respiratory complications under general anaesthesia [7, [10] [11] [12] .
The use of dynamic examination techniques can assist the estimation of possible respiratory decompensation under anaesthesia or if the patient's position is altered. A main dynamic technique to assess the airways is awake fibreoptic tracheobronchoscopy. However, as this technique calls for considerable experience on the part of the examiner and it is either difficult or impossible to evaluate the airways with change in position, bronchoscopy cannot be regarded as the standard means of diagnosis. Nevertheless, a preoperative fibreoptic bronchoscopy as part of awake intubation of MMS patients can still be recommended. Another dynamic method, which over the last few decades has been repeatedly considered as being the most sensitive technique, having also the advantage of being noninvasive, is lung function tests using pneumotachographs [5, 7] . Determination of the flow volume curve (recumbent, sitting), and hence the dynamic expiratory and inspiratory airway flows, provides an indirect indication as to functional airway obstructions. Any flow decrease or formation of a plateau in the expiratory part of the curve suggests an intrathoracic, possibly tumour-related obstruction. A typical finding situation is in which the quotient of maximum expiratory flow (MEF) and inspiratory flow (MIF) at 50% vital capacity is well below 1 (MEF 50 /MIF 50 <1).
If the clinical or CT examination suggests haemodynamic compromise, transthoracic or transoesophageal echocardiography is indicated [13] . In order to visualize and assess compression as well as any potential change in left and right ventricular filling with change in the patient's position, the echocardiography should be performed both in recumbent and in lateral positions.
Preoperative management of mediastinal mass syndrome
If possible, regional anaesthesia should be performed on patients with MMS. If general anaesthesia cannot be avoided for surgical reasons or regional anaesthesia is contraindicated, an in-house clinical algorithm, which has been previously set out, should be used in order to ensure safe patient management. We recommend the following 12 points:
(1) Proper intraoperative management of patients with MMS requires close cooperation between various departments, including anaesthesia, surgery, radiology, ENT and pathology starting during the preoperative stage in order to determine the optimal diagnostic and therapeutic approach. For this reason, patients with mediastinal tumours should be presented to an interdisciplinary team as soon as possible. (2) Preoperative irradiation or chemotherapy may reduce the size of the tumour mass and thus decrease the perioperative complications. Therefore, prior to surgical treatment of a mediastinal tumour, histological verification using CT or ultrasound-guided biopsy and the possibility of irradiation or chemotherapy should be considered and possibly carried out. (3) Prior to induction of general anaesthesia, the anaesthesiologist should make an exact assessment of the size of the tumour, its localization and any possible obstruction of the airways, superior vena cava, pulmonary artery and the heart on the basis of clinical symptoms, CT ( Fig. 1 ) and cardiorespiratory dynamic test findings. (4) According to the clinical symptoms and the diagnostic results, the patient has to be assigned an anaesthetic MMS risk class [10] [safe, unsafe, uncertain (Tables 1 and 2) ]. This helps to standardize perioperative management within the clinic and to bring it in line with international recommendations. (5) In the case of patients with MMS classification of 'uncertain' or 'unsafe', it must be ensured that, in addition to the surgical team, there are enough staff on hand in the operating theatre prior to induction of anaesthesia. In particular, a second anaesthesia specialist, nursing staff and a perfusionist are required. (6) MMS patients should not be given preoperative sedatives producing respiratory depression and muscle relaxation. The reduced blood flow in the superior vena cava also promotes thrombosis and phlebitis. Overall, these altered pharmacokinetic conditions may delay the onset of anaesthetic and emergency drugs and make their efficacy uncertain. Therefore, intravenous injection in the upper extremity is not an effective form of drug administration. For these reasons, the placement of large-bore intravenous access routes in the lower extremity is always recommended. Computed tomography (CT) scan of the chest in different levels, showing a large mediastinal mass (neuroendocrine tumour). The tumour involved the right heart, pericardium, trachea and the ascending aorta. MM, mediastinal mass. Intraoperative management of mediastinal mass syndrome
Induction of anaesthesia should be performed step-bystep with continuous respiratory and haemodynamic monitoring. The use of short-acting medications for rapid control of general anaesthesia in order to maintain normal muscle tone and sufficient spontaneous breathing is recommended [10] . Possible medications for inducing anaesthesia are sevoflurane and etomidate. Because of the very short half-time, our preferred choice of opiate is remifentanil [14] . Airway management is ideally performed as an awake fibreoptic intubation with the patient conscious while maintaining spontaneous breathing. The endotracheal tube used should have the largest inside diameter possible and be able to resist external compression (e.g. spiral reinforced tube). Before removing the fibreoptic scope, the trachea and primary bronchi should be inspected to rule out collapse or an intraluminal obstruction and to confirm the correct position of the endotracheal tube. To this end, the operating table can be tilted in various directions in order to check for obstruction of the airways depending on the patient's position.
Following induction of anaesthesia, the patient often does not have sufficient respiratory effort, and hence, temporary-assisted spontaneous breathing may be necessary. The use of muscle relaxants should be avoided as much as possible. However, if for surgical reasons (e.g. abdominal surgery), the patient needs to be relaxed, the option of unproblematic pressure-controlled respiration, ideally with succinylcholine, injected slowly, must be initially attempted. If mechanical ventilation is possible without a significant increase in airway pressure and/or a maximum ventilation pressure of below 35-40 cmH 2 O, the patient can be relaxed. If pressure-controlled ventilation leads to a disproportionate increase in airway pressure (DP max > 20 cmH 2 O), a critical airway stenosis must be assumed and relaxation is to be avoided. If oxygenation problems occur, it may be helpful to initially change the patient's position or to correct the position of the tube using a fibreoptic bronchoscope.
Management of intraoperative complications
In the event of respiratory or haemodynamic complications, the operating table should initially be tilted into the position that the patient described as 'comfortable' preoperatively. In this position, the tumour-related compression pressure is usually lowest and the airway occlusion or circulatory decompensation can be immediately minimized or remedied. With respiratory decompensation, the obstruction of the trachea or main bronchus can be bypassed by advancing the tube so as to ventilate the distal airway section. In the case of high compression pressure or an obstruction that is located further distal, the only remaining choice is to insert a rigid bronchoscope to ventilate. From a physiological perspective, the return of spontaneous breathing is extremely important, yet in the majority of cases following administration of a short or medium-acting muscle relaxant, this does not happen quickly enough in critical situations. Pharmacological reversal is not recommended for reasons of time and the possible triggering of a bronchial constriction among other factors.
For haemodynamic stabilization, hyperosmolar solutions, inotropes and possibly also blood products are administered. In addition to the occurrence of a cardiocirculatory decompensation syndrome, the possibility of surgical bleeding should be considered. If these measures for haemodynamic and respiratory support fail, only invasive surgical measures are available. Effective treatment of haemodynamic or respiratory decompensation following induction of anaesthesia is prompt surgical decompression of mediastinal organs by median sternotomy and manual surgical tumour elevation. As for high-risk patients classified as 'unsafe', this type of decompensation following anaesthesia induction is to be expected; the option of connection to extracorporeal circulation (ECC) must always be provided. In this context, it is recommended that the femoral vessels be cannulated preoperatively under local anaesthesia [8, 10] . The international literature does not provide standard guidelines for ECC management of patients in the 'uncertain' category. Concepts such as 'standby cardiopulmonary bypass' in which the perfusionist is on standby at a greater or lesser distance from the operating theatre without a primed ECC machine and recommendations such as 'cardiopulmonary bypass available' are not practical and are open to personal interpretation. It must also be remembered that the preparation of the ECC and the necessary organization of staff resources (surgeon, perfusionist) are extremely time-consuming and thus, when the patient's life is at acute risk, cannot be used or may come too late.
Finally, a consensus as to the anaesthetic approach and the management of complications should be reached with the surgical staff, taking into consideration the in-house conditions.
Postoperative management of mediastinal mass syndrome
Following surgery, patients in the 'unsafe' risk category should be transferred to an intensive care unit where the aim should be rapid extubation. The extent of postoperative monitoring for patients in the 'uncertain' risk category should be decided depending on preoperative findings and intraoperative course.
If the mediastinal tumour is completely removed, complications such as respiratory or haemodynamic instability or both are not normally expected. However, if, the neoplasm is subjected to an invasive diagnostic procedure or if the patient is operated outside the mediastinum, all the above-mentioned measures for airway and circulation management must still be kept ready, as decompensation is possible at any time during the postoperative period.
Patients who have been extubated and whose cardiopulmonary and neurological findings are normal can be moved from the recovery room on the basis of the usual criteria. An intermediate care setting is recommended with ECG, blood pressure and saturation monitoring for the first 24 h. 
Conclusion
To our knowledge, this is the first detailed presentation of a standard protocol for anaesthetic management of patients with MMS. Our intention was to design perioperative procedure and response to cardiorespiratory complications as a structured, step-by-step plan in order to present a comprehensible and logical pathway, also for colleagues who manage patients with mediastinal tumours outside thoracic surgery operations. Especially in the case of patients with mediastinal tumours, we believe it is extremely important to develop such a standard protocol. The risk of cardiorespiratory decompensation in conjunction with MMS only partially depends on the particular pathophysiology of the disease. Ignorance, lack of experience and lack of proper perioperative management of the compression syndrome render this a life-threatening disease. We are firmly convinced that a standardized procedure, as described in this article, would increase the anaesthetist's awareness in the management of MMS patients and reduce the likelihood of cardiorespiratory decompensation.
In order to adequately treat patients with mediastinal masses, in addition to a careful preoperative diagnosis, surgical treatment and postoperative care are recommended at a clinic with the necessary infrastructure and experience. Complication-free anaesthetic management depends on a high level of cooperation and communication among the members of the interdisciplinary treatment team. The free lines are reserved for own records. ECC, extracorporeal circulation; MMS, mediastinal mass syndrome; NSAID, nonsteroidal anti-inflammatory drug.
